FEDRATINIB | FEDRATINIB | ATC L01XE57
ANTINEOPLASTIC JANUS ASSOCIATED KINASE 2 INHIBITOR (JAK2) FMS-LIKE TYROSINE KINASE 3 (FLT3) INHIBITOR TREATMENT OF INTERMEDIATE-2 OR HIGH-RISK PRIMARY OR SECONDARY MYELOFIBROSIS (MF) | ORAL | Cmax 3.44 MICROMOLAR Tmax 3 HOUR VD 1770 LITER PPB 92 PERCENT Cl 13 LITER / HOUR HT 114 HOUR SOLUBILITY PRACTICALLY INSOLUBLE IN WATER | JANUS ASSOCIATED KINASE 2 INHIBITOR (JAK2) FMS-LIKE TYROSINE KINASE 3 (FLT3) PDB 4PS5 (CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH TG101348) LIGAND CODE = 2TA (link to the list of PDB complexes) Download experimental 3D coordinates of 2TA with added hydrogens | Tyrosine-protein kinase JAK2 inhibitor O60674 (JAK2_HUMAN) | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |